Please enter your username and password below, if you are not yet a member of Oncology Central remember you can register for free.
Already have an account? Login here
Categories // Disease Area // Genetics
Editor, Jade Parker recently spoke with David Adams, Senior Group Leader at the Wellcome Trust Sanger Institute (Cambridge, UK).
David utilizes DNA sequencing of patients and genetic screens in human cells and mice to identify cancer genes and genetic interactions. In this interview you can find out about:
To see all the videos in this series of interviews with cancer genomics opinion leaders, subscribe to our Youtube channel.
Updated 2 January, 2019